Drugs / Pemetrexe
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01665417 | Aug 2012 → Jul 2017 | adenocarcinoma, non-small cell lung carcinoma | Betta Pharmaceuticals Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pemetrexe | “Chemotherapy Regimen 1：Pemetrexe 500 mg/m\^2 on Day 1” NCT01665417 ↗ |